|
1
|
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG and Long MD: ACG clinical guideline: Ulcerative colitis in adults. Am J Gastroenterol. 114:384–413. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Testa A, Castiglione F, Nardone OM and Colombo GL: Adherence in ulcerative colitis: An overview. Patient Prefer Adherence. 11:297–303. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hindryckx P, Jairath V and D'Haens G: Acute severe ulcerative colitis: From pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 13:654–664. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Null K, Xu Y, Pasquale M, Su C, Marren A, Harnett J, Mardekian J, Manuchehri A and Healey P: Ulcerative colitis treatment patterns and cost of care. Value Health. 20:752–761. 2016.
|
|
5
|
Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT and Ludvigsson JF: Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study. Lancet. 395:123–131. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Damas OM and Abreu MT: Are patients with ulcerative colitis still at increased risk of colon cancer? Lancet. 395:92–94. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tatiya-Aphiradee N, Chatuphonprasert W and Jarukamjorn K: Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol. 30:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kakiuchi N, Yoshida K, Uchino M, Kihara T, Akaki K, Inoue Y, Kawada K, Nagayama S, Yokoyama A, Yamamoto S, et al: Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature. 577:260–265. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang Q, Tao H, Lin Y, Hu Y, An H, Zhang D, Feng S, Hu H, Wang R, Li X, et al: A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Biomaterials. 105:206–221. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Allocca M, Furfaro F, Fiorino G, Gilardi D, D'Alessio S and Danese S: Can IL-23 be a good target for ulcerative colitis? Best Pract Res Clin Gastroenterol. 32-33:95–102. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ebbesen KK, Hansen TB and Kjems J: Insights into circular RNA biology. RNA Biol. 14:1035–1045. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang TT, Han Y, Gao FF, Ye L and Zhang YJ: Effects of circular RNA circ-SOD2 on intestinal epithelial barrier and ulcerative colitis. Beijing Da Xue Xue Bao Yi Xue Ban. 51:805–812. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
13
|
Sun J, Wang X, Wang D, Zhao Z, Zhang L and Zhang J: circAtp9b knockdown alleviates LPS-caused inflammation provided that microRNA-27a is upregulated. Int Immunopharmacol. 78(105925)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N and Shimosegawa T: Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol. 37:699–704. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang T, Chen N, Ren W, Liu F, Gao F, Ye L, Han Y, Zhang Y and Liu Y: Integrated analysis of circRNAs and mRNAs expression profile revealed the involvement of hsa_circ_0007919 in the pathogenesis of ulcerative colitis. J Gastroenterol. 54:804–818. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yamada KM and Araki M: Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis. J Cell Sci. 114:2375–2382. 2001.PubMed/NCBI
|
|
18
|
Li Z, Liu GX, Liu YL, Chen X, Huang XL and Gan HT: Effect of adenovirus-mediated PTEN gene on ulcerative colitis-associated colorectal cancer. Int J Colorectal Dis. 28:1107–1115. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu J, Xu D, Wang Q, Zheng D, Jiang X and Xu L: LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4. Dig Dis Sci. 59:1452–1460. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tokuhira Kitagishi Y, Suzuki M, Minami A, Nakanishi A, Ono Y, Kobayashi K, Matsuda S and Ogura Y: PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review). Int J Mol Med. 35:10–16. 2015.PubMed/NCBI View Article : Google Scholar
|
